Profluent Unveils OpenCRISPR-1, an AI-Designed Gene Editor
The implications of OpenCRISPR-1 are vast and could usher in a new era of genetic medicine where treatments are not only more effective but also more accessible.
Biotech & Health
A collection of 16 posts
Baseimmune Closes $11.3M Series A to Accelerate AI-Designed Vaccines
Founded in 2019, Baseimmune leverages proprietary deep learning algorithms to predict future mutations of pathogens and design synthetic antigen proteins that can provide broader, longer-lasting immune protection.
Bioptimus Raises $35M Seed Funding to Build Biology Foundation Models
Bioptimus’ mission is to accelerate innovation in biomedicine using the latest advancements in AI, specifically large language models.
AI Speeds Up Hunt for New Infectious Disease Treatments
Researchers successfully used generative AI and foundation models to design several small molecule inhibitors for essential target proteins of Mycobacterium tuberculosis and coronaviruses.
Isomorphic Labs Partners with Eli Lilly and Novartis to Propel AI-Driven Drug Discovery
With a combined value of about $3B, the high-profile deals underscore the immense faith that industry leaders have in AI-driven drug discovery as the future of medicine R&D.
AI-Discovered Antibiotics Show Promise Against Deadly MRSA
Published in Nature, the study reveals that these compounds effectively eliminate MRSA in lab dishes and mouse models, while demonstrating minimal toxicity to human cells.
Elucid Secures $80 Million to Drive Adoption of AI-Powered Cardiac Imaging
The company says it will leverage the new capital to expand commercialization and clinical research efforts for its suite of cardiac imaging analysis products.
Google Teases Next Generation of AlphaFold, Expanding AI Structure Prediction Beyond Proteins
This next-generation AlphaFold signifies a dramatic leap in performance and showcases the potential of AI to enhance our understanding of molecular biology.
Google DeepMind's New AI Tool Helps Pinpoint the Causes of Genetic Diseases
In a recently published paper in Science, it was revealed that AlphaMissense had classified a staggering 89% of all possible missense variants — illuminating the pathogenic or benign nature of these mutations.
Medeloop Secures $8M to Pioneer AI-Powered Health Research
The platform aims to merge artificial intelligence with healthcare data, offering research professionals an integrated suite of tools that could radically reduce the timeline for medical discovery.
Generate:Biomedicines Closes $273 Million Series C to Advance AI-Powered Drug Pipeline
Funding will advance pipeline of 17 existing programs and approximately 10 new starts annually.
Paige and Microsoft are Building the World's Largest AI Model to Detect Cancer
The companies believe the model will enable major leaps in accuracy as well as entirely new capabilities for cancer detection and diagnostics.
Inceptive Raises $100 Million to Design New Vaccines and Therapies with AI
Investors are betting big on startups like Inceptive that are merging biotech and AI. This funding round triples Inceptive's valuation to over $300 million since it's $20M seed round in 2021.
Researchers Used AI to Give a Paralyzed Woman Her Voice Back
Not only does the implant use Ann's brain signals to generate speech, but it also animates a digital avatar with facial expressions, mimicking the natural nuances of human communication.
Genesis Therapeutics Closes $200M Series B to Advance AI-Discovered Drug Pipeline
The oversubscribed round was co-led by an undisclosed U.S. life sciences investor and returning lead investor Andreessen Horowitz.
Generative AI is Transforming Healthcare: What Does That Mean for You?
Learn about the groundbreaking impact of generative AI in healthcare, including faster drug discovery, more accurate diagnosis, personalized treatment, and efficient operations.